Renal Cell Carcinoma Knowledge Centre launched on EU doctor website

The launch of a new interactive online ‘Knowledge Centre’ on Renal Cell Carcinoma (RCC) has been announced by EPG Health Media. The Knowledge Centre is designed to support healthcare professionals involved in the management of patients with RCC and they are invited to access the resource for free at EPG Online (http://www.epgonline.org/Renal-Cell-Carcinoma/).

RCC is the most common form of kidney cancer in adults. While it is a global problem, RCC rates are highest in North America, Europe and Australia. Numerous factors have been associated with an increased risk of RCC, including obesity and smoking, though it has been suggested that the worldwide increase in incidence may be explained in part by an increase in detection due to use of enhanced imaging techniques.

Initial treatment is most commonly surgery to remove the tumour, which is resistant to radiation therapy and chemotherapy. Although they have yet demonstrated improved survival, targeted cancer therapies have improved the outlook for RCC.

Sponsored by Novartis Farma S.p.A, the Renal Cell Carcinoma Knowledge Centre includes a classification of tumour types, diagnosis and staging of the disease and a full management and a treatment section including information on surgery, systemic treatments, clinical factors and guidelines.

“Healthcare professionals face a huge challenge in identifying RCC and also in deciding appropriate course of treatment for individual RCC patients.” Said Chris Cooper, EPG Health Media “By working with our partner Novartis we aim to provide doctors visiting epgonline.org with a resource that supports them in making these important decisions.”

“The RCC knowledge center is a clear example of our commitment to provide educational support to our health professionals in this disease.” Said a Novartis Oncology spokesperson “Novartis Oncology provides healthcare solutions that address the evolving needs of patients and societies through consistently delivering innovative therapies which significantly reduce the burden of cancer, we will: improve and extend the lives of cancer patients as we make therapies broadly available; become the premier Oncology company, respected by customers, competitors and society.”

Established in 2000, EPG Online is an independent website, providing healthcare professionals with free access to the most recent best practice diagnosis and patient management guidance. In addition to in excess of 25 disease Knowledge Centres, EPG Online includes a databases of prescription drugs in 9 European languages (searchable by name and indication), clinical trial reports and treatment guidelines.

With over 300,000 members and more than 110,000 pages of clinical content, EPG Online represents the largest and most widely subscribed to disease, medicines and free educational platform for European doctors. The website is operated by EPG Health Media, part of UK based IMR International Ltd, a private limited Company specialising in the delivery of electronic publishing; communications solutions and market research for the health industry.

Established in 2000, EPG Online is an independent website, providing healthcare professionals with free access to the most recent best practice diagnosis and patient management guidance. In addition to in excess of 25 disease Knowledge Centres, EPG Online includes a databases of prescription drugs in 9 European languages (searchable by name and indication), clinical trial reports and treatment guidelines.

Press Officer
EPG Health Media
3rd Floor - Royal Victoria House
51-55 The Pantiles
Tunbridge Wells
Kent
TN2 5TE
UK

E-MAIL: press(at)epghealthmedia.com
WEB: www.epghealthmedia.com
TEL: 01892 526 776
FAX: 01892 527 669

This release was published on openPR.